‘Game-changing’ immunotherapy cancer drug boosts survival rates five-fold
| | | | |

‘Game-changing’ immunotherapy cancer drug boosts survival rates five-fold

This article was taken from: https://www.telegraph.co.uk/news/2019/09/10/game-changing-immunotherapy-cancer-drug-boosts-survival-rates/ By Laura Donnelly, health editor An ew immunotherapy cancer drug boosts survival rate five-fold, scientists from Yale have found. Patients with advanced lung cancer were far more likely to be alive after five years, compared with those given standard chemotherapy. The immunotherapy drug nivolumab, which is used for several cancers, works…